Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Dakshidin Corporation, Inc. (DKSC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0012+0.0001 (+9.09%)
At close: 12:36PM EDT
Advertisement

Dakshidin Corporation, Inc.

2250 NW 114th Avenue
Unit 1P
Miami, FL 33172-3652
United States
888-818-9167

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Christopher Robin HaighCEO & DirectorN/AN/AN/A
Mr. Charles L. Nuzum Sr., CPACFO & Sec. to the Board of DirectorsN/AN/A1949
Mr. Robert Mack PeakChief Marketing OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.

Corporate Governance

Dakshidin Corporation, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement